期刊文献+

可溶性白细胞分化抗原14亚型对老年急性左心衰竭合并肺炎的临床诊断价值 被引量:5

Clinical diagnostic value of presepsin in elderly patients of acute left heart failure complicated with pneumonia
原文传递
导出
摘要 目的探讨白细胞分化抗原14亚型(sCD14-ST,presepsin)对老年急性左心衰竭合并细菌性肺炎的临床诊断价值。方法回顾性分析本院急诊科2017年8月至2018年8月入院的单纯老年急性左心衰竭(对照组)和老年急性左心衰竭合并细菌性肺炎患者共111例。应用化学发光免疫测试法检测所有研究对象外周血presepsin,同时搜集其他临床资料如发热、血降钙素原、C反应蛋白、血白细胞等。组间比较以上参数的差异,Logistic回归分析影响老年急性左心衰竭合并细菌性肺炎诊断的独立危险因素;绘制受试者工作特征曲线,分析presepsin、降钙素原和白细胞对于鉴别诊断的价值。结果合并细菌性肺炎组患者入院时血presepsin(500.9±283.5)ng/L高于对照组(167.7±102.3)ng/L,差异有统计学意义(t=-7.902,P=0.000)。多因素Logistic回归分析结果表明presepsin升高、降钙素原升高和发热是诊断合并细菌性肺炎的独立危险因素。ROC曲线结果显示入院时血presepsin的ROC曲线下面积为0.887(95%CI:0.825~0.949,P<0.001),降钙素原的ROC曲线下面积为0.794(95%CI:0.704~0.885,P<0.001),血白细胞的ROC曲线下面积为0.566(95%CI:0.455~0.678,P=0.231)。presepsin取截断值为227 ng/L时诊断的敏感度为82.0%,特异度为83.6%,阳性似然比为5,阴性似然比为0.22,阳性预测值为80.4%,阴性预测值为85%。结论Presepsin对鉴别老年急性左心衰竭合并细菌性肺炎有重要诊断价值。 Objective To investigate the clinical diagnostic value of soluble leukocyte differentiation antigen 14 subtype(sCD14-ST,presepsin)in elderly patients with acute left heart failure(AHF)complicated with bacterial pneumonia.Methods The data of 111 elderly patients with acute left heart failure complicated with bacterial pneumonia or acute left heart failure(the control group)who were admitted into emergency department from August 2017 to August 2018 were retrospectively analyzed.Chemilluminescence immunoassay was performed to detect presepsin in all patients.And meanwhile,fever or not,presepsin,procalcitonin(PCT),C-reaction protein(CRP)and other clinical data were compared between the two groups.Univariate and multivariate logistic regression analysis were adopted to screen the risk factor influencing the diagnosis.The receiver operating characteristic(ROC)curve was used to analyze the clinical value of presepsin on diagnosing acute left heart failure complicated with bacterial pneumonia in elderly patients.Results Presepsin of the group complicated with bacterial pneumonia was signifi cantly higher than that of the control group[(500.9±283.5)ng/L vs.(167.7±102.3)ng/L,t=-7.902,P=0.000].The logistic regression analysis,showed that fever,presepsin and procalcitonin were independent risk factors for AHF combined with bacterial pneumonia diagnosis.The area under ROC curve(AUC)of presepsin,PCT and WBC was 0.887(95%CI:0.825-0.949,P<0.001),0.794(95%CI:0.704-0.885,P<0.001),and 0.566(95%CI:0.455-0.678,P=0.231),respectively.The optimal threshold value of presepsin was 227 ng/L,the sensitivity was 82.0%,specifi city was 83.6%,the positive likelihood ratio was 5,the negative likelihood ratio was 0.22,the positive predictive value was 80.4%,and the negative predictive value was 85%.Conclusions Presepsin has an important diagnostic value for the identifi cation of AHF combined with bacterial pneumonia in elderly patients.
作者 胡振 张新超 Hu Zhen;Zhang Xinchao(Department of Emergency,Beijing Hospital,National Center of Gerontology,Institute of Geriatric Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China)
机构地区 北京医院急诊科
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2021年第8期987-991,共5页 Chinese Journal of Emergency Medicine
基金 卫生行业科研专项基金《中国老年人综合评估和医疗服务体系建立及推广》子课题“老年急症评估”(201002011) 睿E(睿意)急诊医学研究专项基金(R2018028)。
关键词 可溶性白细胞分化抗原14亚型 降钙素原 急性心力衰竭 肺炎 细菌感染 老年 急诊 诊断 Soluble leukocyte differentiation antigen 14 subtype Procalcitonin Acute heart failure Pneumonia Bacterial infection Elderly Emergency Diagnosis
  • 相关文献

参考文献7

二级参考文献162

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:786
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3038
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis,assessment of severity,sntimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163,1730-1754.
  • 5Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guildelines foe the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 6Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Managenment of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus Pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewing S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9British Thoracic Society Standards of Care Committee.BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.Thorax,2001,56 Suppl 4:Ⅳ1-Ⅳ64.
  • 10Whang KT, Vath SD, Becker KL, et al. Procalcitonin and pro-inflammatory cytokine interactions in sepsis [ J]. Shock,2000,14(1): 73-78.

共引文献6052

同被引文献72

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部